Definitive Healthcare Financials
DH Stock | USD 4.93 0.08 1.60% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.36 | 0.3111 |
|
| |||||
Current Ratio | 1.66 | 2.01 |
|
|
Investors should never underestimate Definitive Healthcare's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Definitive Healthcare's cash flow, debt, and profitability to make informed and accurate decisions about investing in Definitive Healthcare Corp.
Net Income |
|
Definitive | Select Account or Indicator |
Understanding current and past Definitive Healthcare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Definitive Healthcare's financial statements are interrelated, with each one affecting the others. For example, an increase in Definitive Healthcare's assets may result in an increase in income on the income statement.
Definitive Healthcare Corp Earnings Geography
Definitive Healthcare Stock Summary
Definitive Healthcare competes with National Research, Evolent Health, Simulations Plus, Privia Health, and HealthStream. Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts. Definitive Healthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 676 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US24477E1038 |
CUSIP | 24477E103 |
Location | Massachusetts; U.S.A |
Business Address | 492 Old Connecticut |
Sector | Health Care Technology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.definitivehc.com |
Phone | 508 720 4224 |
Currency | USD - US Dollar |
Definitive Healthcare Key Financial Ratios
Return On Equity | -0.55 | ||||
Profit Margin | (1.42) % | ||||
Operating Margin | 0.01 % | ||||
Price To Sales | 2.26 X | ||||
Revenue | 251.41 M |
Definitive Healthcare Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 1.7B | 2.1B | 2.1B | 1.8B | 2.1B | 2.1B | |
Other Current Liab | 16.1M | 26.2M | 21.7M | 21.9M | 25.2M | 22.7M | |
Net Debt | 437.1M | (116.8M) | 128.9M | 137.0M | 123.3M | 162.7M | |
Retained Earnings | (109.9M) | (17.7M) | (23.7M) | (227.5M) | (204.7M) | (194.5M) | |
Accounts Payable | 5.7M | 4.7M | 3.9M | 5.8M | 6.7M | 4.9M | |
Cash | 24.8M | 387.5M | 146.9M | 131.0M | 150.6M | 153.7M | |
Other Assets | 6.6M | 12.8M | 16.4M | 13.5M | 15.5M | 11.5M | |
Long Term Debt | 457.2M | 263.8M | 255.8M | 242.6M | 218.3M | 264.7M | |
Net Receivables | 33.1M | 43.3M | 58.8M | 59.2M | 68.1M | 48.3M | |
Other Current Assets | 6.0M | 13.4M | 23.1M | 13.1M | 15.1M | 12.6M | |
Total Liab | 549.8M | 612.7M | 633.8M | 626.7M | 720.7M | 644.1M | |
Net Invested Capital | 1.7B | 1.1B | 1.2B | 1.1B | 1.0B | 1.1B | |
Short Long Term Debt | 4.7M | 6.9M | 8.6M | 13.8M | 15.8M | 8.4M | |
Total Current Assets | 63.8M | 451.6M | 413.7M | 380.4M | 437.5M | 296.1M | |
Capital Stock | 1.3B | 97K | 105K | 117K | 105.3K | 100.0K | |
Net Working Capital | (24.9M) | 333.8M | 281.2M | 223.2M | 256.7M | 171.5M | |
Short Term Debt | (50.9M) | 6.9M | 11.6M | 16.0M | 18.4M | 19.3M | |
Intangible Assets | 410.2M | 352.5M | 350.7M | 323.1M | 290.8M | 301.3M | |
Common Stock | 1.3B | 97K | 105K | 117K | 105.3K | 100.0K |
Definitive Healthcare Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Interest Expense | 36.5M | 25.9M | 8.4M | 15.2M | 13.7M | 16.7M | |
Total Revenue | 118.3M | 166.2M | 222.7M | 251.4M | 289.1M | 185.7M | |
Gross Profit | 87.8M | 125.5M | 180.0M | 203.9M | 234.5M | 140.7M | |
Operating Income | (10.7M) | (18.7M) | (23.1M) | (329.8M) | (296.8M) | (282.0M) | |
Ebit | (14.7M) | (36.9M) | (33.5M) | (293.0M) | (263.7M) | (250.5M) | |
Research Development | 11.1M | 18.6M | 34.9M | 42.4M | 48.8M | 25.2M | |
Ebitda | 44.9M | 23.1M | 23.4M | (241.2M) | (217.1M) | (206.2M) | |
Cost Of Revenue | 30.5M | 40.7M | 42.6M | 47.5M | 54.6M | 44.9M | |
Income Before Tax | (51.2M) | (60.6M) | (39.4M) | (308.2M) | (277.4M) | (263.5M) | |
Net Income | (87.6M) | (61.3M) | (22.3M) | (202.4M) | (182.1M) | (173.0M) | |
Income Tax Expense | 36.5M | 675K | (17.2M) | (18.6M) | (16.7M) | (15.9M) |
Definitive Healthcare Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Investments | (23.9M) | (46.7M) | (248.9M) | (154.1M) | (138.7M) | (145.6M) | |
Change In Cash | 16.2M | 362.7M | (240.6M) | (16.0M) | (14.4M) | (13.6M) | |
Free Cash Flow | 21.8M | 18.5M | 27.3M | 38.2M | 43.9M | 27.6M | |
Depreciation | 59.6M | 59.9M | 56.9M | 51.8M | 59.5M | 57.6M | |
Other Non Cash Items | 13.7M | 20.7M | 13.1M | 192.2M | 221.0M | 232.1M | |
Dividends Paid | 2.9M | 8.1M | 12.9M | 12.3M | 14.1M | 9.5M | |
Capital Expenditures | 1.4M | 6.7M | 8.3M | 3.0M | 3.4M | 4.7M | |
Net Income | (51.2M) | (61.3M) | (22.3M) | (202.4M) | (182.1M) | (173.0M) | |
End Period Cash Flow | 24.8M | 387.5M | 146.9M | 131.0M | 150.6M | 153.7M |
Definitive Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Definitive Healthcare's current stock value. Our valuation model uses many indicators to compare Definitive Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Definitive Healthcare competition to find correlations between indicators driving Definitive Healthcare's intrinsic value. More Info.Definitive Healthcare Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Definitive Healthcare's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Definitive Healthcare's earnings, one of the primary drivers of an investment's value.Definitive Healthcare's Earnings Breakdown by Geography
Definitive Healthcare Systematic Risk
Definitive Healthcare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Definitive Healthcare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Definitive Healthcare correlated with the market. If Beta is less than 0 Definitive Healthcare generally moves in the opposite direction as compared to the market. If Definitive Healthcare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Definitive Healthcare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Definitive Healthcare is generally in the same direction as the market. If Beta > 1 Definitive Healthcare moves generally in the same direction as, but more than the movement of the benchmark.
Definitive Healthcare Thematic Clasifications
Definitive Healthcare Corp is part of several thematic ideas from Data Storage to Health Management. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasToday, most investors in Definitive Healthcare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Definitive Healthcare's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Definitive Healthcare growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Definitive Healthcare January 30, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Definitive Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Definitive Healthcare Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Definitive Healthcare Corp based on widely used predictive technical indicators. In general, we focus on analyzing Definitive Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Definitive Healthcare's daily price indicators and compare them against related drivers.
Downside Deviation | 2.57 | |||
Information Ratio | 0.054 | |||
Maximum Drawdown | 16.28 | |||
Value At Risk | (4.35) | |||
Potential Upside | 5.83 |
Complementary Tools for Definitive Stock analysis
When running Definitive Healthcare's price analysis, check to measure Definitive Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definitive Healthcare is operating at the current time. Most of Definitive Healthcare's value examination focuses on studying past and present price action to predict the probability of Definitive Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Definitive Healthcare's price. Additionally, you may evaluate how the addition of Definitive Healthcare to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |